
₹287,181.56 Original price was: ₹287,181.56.₹235,489.00Current price is: ₹235,489.00.
Lynparza 150mg Tablet by Arogya provides moderate-dose therapy for cancer patients, offering reliable efficacy and safe, clinically supported treatment.
| Country of Origin | United Kingdom |
|---|---|
| Manufacturer | ASTRAZENECA PHARMA INDIA LTD |
| Pack Size | 56 Tablet(s) In A Box |
| Product Name | LYNPARZA 150MG TABLET |
| SKU | AROG-LNP150 |
| Salt Composition | OLAPARIB |
| Storage | Store at 20°C to 25°C |
| Strength | 150mg |
Lynparza 150mg Tablet is an anticancer drug belonging to the category of poly adenosine diphosphate-ribose polymerase (PARP) inhibitor, containing the active ingredient Olaparib. It is used to treat pancreatic, and prostate cancer. Cancer is a disease in which cells multiply uncontrollably and abnormally. This medication can be given alone or in combination with other anticancer medications.
Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting treatment, if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.
Lynparza tablet is not recommended during pregnancy as it might harm the unborn baby and lead to miscarriage. Hence, it is advisable to do a pregnancy test before starting this treatment for women of childbearing age. Ideally, it is better to continue birth control methods for a minimum of 6 months after completion of the treatment. Avoid breastfeeding your baby while you are on the treatment, as it is unknown whether Lynparza 150mg Tablet passes into the breast milk.
Lynparza 150mg uses are to treat:
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Lynparza 150mg side effects are:
Common:
Q1. How effective is Lynparza 150mg Tablet?
Lynparza 150mg Tablet and other PARP inhibitors effectively prevent ovarian cancer relapse by 40-70%.
Q2. What type of medication is Lynparza 150mg Tablet?
Lynparza 150mg Tablet is a targeted anticancer drug belonging to the category of PARP inhibitors. It specifically acts against ovarian cancer due to mutation in BRCA genes.
Q3. How long should you take PARP inhibitors?
PARP inhibitors are intended to be taken for as long as your healthcare provider recommends. Some studies suggest taking PARP inhibitors for up to 2 years.
Q4. Is Lynparza 150mg Tablet used as a standalone treatment in cancers?
Lynparza 150mg Tablet is usually indicated as maintenance therapy after a person completes a platinum-based chemotherapy regimen for ovarian cancer. However, newer studies are evaluating its solitary efficacy in treating different types of cancers.
Q5. What are the long-term effects of Lynparza 150mg Tablet?
Lynparza 150mg Tablet may increase the risk of bone marrow diseases (myelodysplastic syndrome or Acute Myeloid Leukemia), lung problems (pneumonitis), and blood clots (venous thromboembolism).
Arogya’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Arogya. Our mission is to support, not replace, the doctor-patient relationship.


